IRIS Accounts Production v23.3.1.45 06960233 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069602332022-07-31069602332023-07-31069602332022-08-012023-07-31069602332021-07-31069602332021-08-012022-07-31069602332022-07-3106960233ns10:Originalns15:EnglandWales2022-08-012023-07-3106960233ns14:PoundSterlingns10:Original2022-08-012023-07-3106960233ns10:Originalns10:Director12022-08-012023-07-3106960233ns10:Original2022-08-012023-07-3106960233ns10:Original2023-07-3106960233ns10:Originalns10:PrivateLimitedCompanyLtd2022-08-012023-07-3106960233ns10:Originalns10:SmallEntities2022-08-012023-07-3106960233ns10:Originalns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3106960233ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3106960233ns10:SmallCompaniesRegimeForAccountsns10:Original2022-08-012023-07-3106960233ns10:Originalns10:FullAccounts2022-08-012023-07-3106960233ns10:Original12022-08-012023-07-3106960233ns10:Originalns10:OrdinaryShareClass12022-08-012023-07-3106960233ns10:Originalns10:Director22022-08-012023-07-3106960233ns10:Originalns10:Director32022-08-012023-07-3106960233ns10:Originalns10:RegisteredOffice2022-08-012023-07-3106960233ns10:Original2022-07-3106960233ns10:Originalns5:CurrentFinancialInstruments2023-07-3106960233ns10:Originalns5:CurrentFinancialInstruments2022-07-3106960233ns5:ShareCapitalns10:Original2023-07-3106960233ns5:ShareCapitalns10:Original2022-07-3106960233ns10:Originalns5:SharePremium2023-07-3106960233ns10:Originalns5:SharePremium2022-07-3106960233ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-07-3106960233ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-3106960233ns10:Original2021-08-012022-07-3106960233ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-07-3106960233ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-08-012023-07-3106960233ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-07-3106960233ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-07-3106960233ns10:Originalns5:PlantMachinery2022-07-3106960233ns10:Originalns5:MotorVehicles2022-07-3106960233ns10:Originalns5:ComputerEquipment2022-07-3106960233ns10:Original2022-07-3106960233ns10:Originalns5:PlantMachinery2022-08-012023-07-3106960233ns10:Originalns5:MotorVehicles2022-08-012023-07-3106960233ns10:Originalns5:ComputerEquipment2022-08-012023-07-3106960233ns10:Originalns5:PlantMachinery2023-07-3106960233ns10:Originalns5:MotorVehicles2023-07-3106960233ns10:Originalns5:ComputerEquipment2023-07-3106960233ns10:Originalns5:PlantMachinery2022-07-3106960233ns10:Originalns5:MotorVehicles2022-07-3106960233ns10:Originalns5:ComputerEquipment2022-07-3106960233ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3106960233ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-3106960233ns10:Originalns10:OrdinaryShareClass12023-07-3106960233ns10:Originalns10:Director332022-07-3106960233ns10:Originalns10:Director332021-07-3106960233ns10:Originalns10:Director332022-08-012023-07-3106960233ns10:Originalns10:Director332021-08-012022-07-3106960233ns10:Originalns10:Director332023-07-3106960233ns10:Originalns10:Director332022-07-3106960233ns10:Original1ns10:Director12022-07-3106960233ns10:Original1ns10:Director12021-07-3106960233ns10:Original1ns10:Director12022-08-012023-07-3106960233ns10:Original1ns10:Director12021-08-012022-07-3106960233ns10:Original1ns10:Director12023-07-3106960233ns10:Original1ns10:Director12022-07-31
REGISTERED NUMBER: 06960233 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2023

FOR

HEALTHY SUPPLIES LIMITED

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HEALTHY SUPPLIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2023







DIRECTORS: Ms R M Manahai
Ms A W Rosinska
D Samantzopoulos





REGISTERED OFFICE: Unit 1 South Coast House
Lancing Business Park
35 Chartwell Road
Lancing
West Sussex
BN15 8TU





REGISTERED NUMBER: 06960233 (England and Wales)





ACCOUNTANTS: Galloways Accounting (Hove) Limited
The Old Casino
28 Fourth Avenue
Hove
East Sussex
BN3 2PJ

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 3 1,705 5,311
Tangible assets 4 90,621 117,345
92,326 122,656

CURRENT ASSETS
Stocks 5 357,013 301,243
Debtors 6 108,495 99,819
Cash at bank and in hand 267,134 222,351
732,642 623,413
CREDITORS
Amounts falling due within one year 7 263,920 223,449
NET CURRENT ASSETS 468,722 399,964
TOTAL ASSETS LESS CURRENT
LIABILITIES

561,048

522,620

PROVISIONS FOR LIABILITIES 22,403 22,676
NET ASSETS 538,645 499,944

CAPITAL AND RESERVES
Called up share capital 8 16,000 16,000
Share premium 25,200 25,200
Retained earnings 497,445 458,744
SHAREHOLDERS' FUNDS 538,645 499,944

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 January 2024 and were signed on its behalf by:



Ms R M Manahai - Director


HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and form the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

SALE OF GOODS

Turnover form the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant & Machinery25% Straight line
Motor Vehicles25% Straight line
Computer Equipment 25% and 50% Straight line


Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 25 (2022 - 29 ) .

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

3. INTANGIBLE FIXED ASSETS
Development
costs
£   
COST
At 1 August 2022
and 31 July 2023 10,821
AMORTISATION
At 1 August 2022 5,510
Amortisation for year 3,606
At 31 July 2023 9,116
NET BOOK VALUE
At 31 July 2023 1,705
At 31 July 2022 5,311

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 August 2022 192,309 550 28,146 221,005
Additions 6,700 - - 6,700
At 31 July 2023 199,009 550 28,146 227,705
DEPRECIATION
At 1 August 2022 76,427 550 26,683 103,660
Charge for year 32,341 - 1,083 33,424
At 31 July 2023 108,768 550 27,766 137,084
NET BOOK VALUE
At 31 July 2023 90,241 - 380 90,621
At 31 July 2022 115,882 - 1,463 117,345

5. STOCKS
2023 2022
£    £   
Stocks 357,013 301,243

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,892 3,688
Other debtors 49,240 39,972
Directors' loan accounts 1,362 2,577
VAT 16,061 15,601
Prepayments and accrued income 39,940 37,981
108,495 99,819

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 134,905 163,320
Tax 57,842 7,393
Social security and other taxes 15,129 11,266
Other creditors 51,578 39,324
Accruals and deferred income 4,466 2,146
263,920 223,449

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
16,000 Ordinary shares 1 16,000 16,000

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 July 2023 and 31 July 2022:

2023 2022
£    £   
D Samantzopoulos
Balance outstanding at start of year 487 -
Amounts advanced 6,575 487
Amounts repaid (6,469 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 593 487

Ms R M Manahai
Balance outstanding at start of year 2,090 -
Amounts advanced 30,181 2,090
Amounts repaid (31,501 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 770 2,090

These loans are interest free and repayable on demand. Both loans were repaid within 9 months of the year end.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is D Samantzopoulos.

This was by virtue of his 51% holding of the issued share capital.